Mahamaya Lifesciences Ltd IPO

Mahamaya Lifesciences Ltd IPO

Our company specializes in the manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs). We began our journey by focusing on import and registration of vital pesticide molecules (Technical) that were not produced domestically in India. We imported these molecules after lot of product research and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India. After successful registration we marketed these molecules both as technical and as value added end use formulations for both domestic manufacturers and MNCs.

Mahamaya Lifesciences Ltd IPO Details

Total Shares Offered

₹ 61,78,800

Offer to Public

5,40,000

Retail Max (Shares)

₹ 20,59,200

Pre Issue Promoters Holding

₹ 1,37,28,000

Exchange

BSE

Issue size

₹ 70.44 Cr

IPO Open Date

Nov 11, 2025

Close Date

Nov 13, 2025

Lot Size

2400

Min Investment

₹ 2,59,200

Issue Type

Book Building - SME

Listing Date

Nov 18, 2025

Mahamaya Lifesciences Ltd IPO Dates

check-icon
Nov 11, 2025
Opening date
check-icon
Nov 13, 2025
Closing date
check-icon
Nov 14, 2025
Basis of Allotment
check-icon
Nov 17, 2025
Initiation of Refunds
check-icon
Nov 17, 2025
Credit of Shares
check-icon
Nov 18, 2025
Listing date

Details

SectorType
SectorPesticides
Sub SectorAgrochemicals - Indian
Issue TypeBook Building - SME

Subscription Status

*Values are in Lakhs

Investor Type

QIB

NII

Retail

Employee

Total

Mahamaya Lifesciences Ltd Financial Status

Income Statement

Particulars (In Rs. Crores)

Balance Sheet

Particulars (In Rs. Crores)
Particulars (in Rs. Crores)FY23FY22FY21
Revenue from operations19.04161.57137.08
EBITDA20.8110.347.85
PAT12.825.473.73
Total Assets157.2987.8754.38
Share Capital17.771.251.25
Total Borrowings52.7743.4028.20
Operating Activities (Net Cash)14.596.885.05
Investing Activities (Net Cash)-4.07-2.91-2.12
Financing Activities (Net Cash)52.7743.4028.20
Net Cashflow3.923.011.40

About Mahamaya Lifesciences Ltd

Our Company was originally incorporated as a private limited Company under the name of Mahamaya Life Sciences Private Limited under the provisions of the Companies Act, 1956 and certificate of incorporation was issued by the Assistant Registrar of Companies, NCT of Delhi & Haryana, on May 07, 2002. Further, our Company name was changed from Mahamaya Life Sciences Private Limited to Mahamaya Lifesciences Private Limited and a fresh certificate of Incorporation dated February 15, 2016 was issued by the Registrar of Companies, Delhi. Moreover, a special resolution was passed at the Extra-Ordinary General Meeting of our Company held on October 29, 2024 for conversion of our Company into a public limited Company and the name of our Company was changed from Mahamaya Lifesciences Private Limited to Mahamaya Lifesciences Limited. A fresh certificate of incorporation consequent to change of name was issued by the Registrar of Companies, Delhi on November 19, 2024. The Corporate Identity Number of our Company is U24233DL2002PLC115261.

India is among the top five global producers of agrochemicals, playing a vital role in crop protection. The industry has expanded rapidly, growing at a CAGR of 13.3% from USD 814 million in 2019 to USD 1,342 million in 2023, and is projected to grow at 7.6% CAGR from 2023 to 2029. Pesticide production grew at a CAGR of 4.5%, reaching 258 thousand tonnes in 2022-23. India is a net exporter of pesticides, with exports increasing at a CAGR of 8.1% from 2018-19 to 2022-23, surpassing domestic consumption. The total export value reached Rs.43,223 crore (US$ 5.50 billion) in 2022-23. Despite strong exports, India imports pesticides, primarily from China, which accounted for 51.97% of total imports in 2022-23. The agrochemical sector includes insecticides, herbicides, fungicides, and biopesticides, with herbicides dominating global crop protection. Due to advanced formulations, India's chemical pesticide consumption declined at a CAGR of 3.2% from 2018-19 to 2022-23. Industry growth is driven by rising agricultural output, population growth, government initiatives, and increased awareness of biopesticides. Government support includes organic farming promotion and financial aid for farmers. With increasing global demand and the Make in India push, the industry is set for continued expansion. Strengthening domestic production and reducing import dependence remain key priorities for India's agrochemical sector.

Our company specializes in the manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs). We began our journey by focusing on import and registration of vital pesticide molecules (Technical) that were not produced domestically in India. We imported these molecules after lot of product research and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India. After successful registration we marketed these molecules both as technical and as value added end use formulations for both domestic manufacturers and MNCs.

Peer Comparison:

  • Nova Agritech Ltd
  • Bhagiradha Chemicals & Industries Ltd

Mahamaya Lifesciences Ltd Key Points

Strengths

Experienced management team consisting of experts.

Capability to introduce vital products for Indian Agriculture.

Development of export opportunities of products.

Ability to develop brands.

Cordial relationships with suppliers of raw materials.

Risk

Its top ten customers constituted 71.35%, 76.26%, 83.14% and 71.12% of our sales for the period ended June 30, 2025 and for the financial year ended March 31, 2025, March 31, 2024, March 31, 2023 respectively. Absence of large number of customers, dependence on few customers and creating a customer concentration risk which may have an adverse impact on its business operations and financial performance.

The Company has not entered into long-term agreements with its customers for purchasing the company products nor for the supply of raw materials with its suppliers. The company is subject to uncertainties in demand/supply and there is no assurance that these customers and suppliers will continue to purchase its products or sell raw materials to it or that they will not scale down their orders. This could impact the business and financial performance of the Company.

Raw materials constitute a significant percentage of the Company's total expenses. Any increase in prices and any decrease in the supply would materially adversely affect the Company's business.

Strategy

Enhancing manufacturing capabilities and expand our product portfolio with advanced safer, ecofriendly chemical and biological crop care solutions.

Research and Development.

Expanding Bio-Product & Herbicide segment.

Maintaining relationships with customers.

Strengthening up our business through effective branding and promotional activities.

How To Apply for Mahamaya Lifesciences Ltd IPO Online?

Step 1:

Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

FAQs on IPO (Initial Public Offering)

What is the issue size of the Mahamaya Lifesciences Ltd IPO?

close
Mahamaya Lifesciences Ltd's IPO offers shares for up to 64.28 It begins on Nov 11, 2025 and ends on Nov 13, 2025.

What is the price of the Mahamaya Lifesciences Ltd IPO?

close
The price of Mahamaya Lifesciences Ltd IPO ranges between ₹108 to ₹114 per share.

What are the open and close dates for the Mahamaya Lifesciences Ltd IPO?

close
The Mahamaya Lifesciences Ltd IPO opens on Nov 11, 2025 and closes on Nov 13, 2025.

When will the Mahamaya Lifesciences Ltd IPO be allotted?

close
The allotment for the Mahamaya Lifesciences Ltd IPO will be finalised on Nov 14, 2025. The shares will be listed on BSE and NSE on Nov 18, 2025.

What is the minimum lot size required for Mahamaya Lifesciences Ltd IPO?

close
The minimum lot size for Mahamaya Lifesciences Ltd IPO is 2400 shares, priced between ₹108 to ₹114 per share.

What is the GMP of Mahamaya Lifesciences Ltd IPO?

close
The GMP (Grey Market Premium) of Mahamaya Lifesciences Ltd IPO fluctuates based on market demand and sentiment.

How do you check the allotment status of Mahamaya Lifesciences Ltd IPO?

close
To check the allotment status of Mahamaya Lifesciences Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

Where is the Mahamaya Lifesciences Ltd IPO getting listed?

close
The Mahamaya Lifesciences Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Nov 11, 2025, and closes on Nov 13, 2025. The allotment is finalised on Nov 14, 2025.

How do you apply for the Mahamaya Lifesciences Ltd IPO?

close
To apply for the Mahamaya Lifesciences Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions